Research output per year
Research output per year
Personal profile
Research interests
My interests surround aggressive subgroups of breast cancer, HER2 overexpressed and triple negative breast cancer, some of which disproportionately affect young women with poor prognosis, hence an area yearning for innovative, more effective options.
Clinical interests
Breast cancer, medical oncology, breast health
Fingerprint
Dive into the research topics where Nusayba Bagegni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)
Ademuyiwa, F. O., Northfelt, D. W., O’Connor, T., Levine, E., Luo, J., Tao, Y., Hoog, J., Laury, M. L., Summa, T., Hammerschmidt, T., Guo, Z., Frith, A., Weilbaecher, K., Opyrchal, M., Aft, R., Clifton, K., Suresh, R., Bagegni, N., Hagemann, I. S. & Iglesia, M. D. & 1 others, , Dec 2023, In: npj Breast Cancer. 9, 1, 1.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
Hensing, W. L., Gerratana, L., Clifton, K., Medford, A. J., Velimirovic, M., Shah, A. N., Amico, P. D., Reduzzi, C., Zhang, Q., Dai, C. S., Denault, E. N., Bagegni, N. A., Opyrchal, M., Ademuyiwa, F. O., Bose, R., Behdad, A., Ma, C. X., Bardia, A., Cristofanilli, M. & Davis, A. A., Aug 15 2023, In: Clinical Cancer Research. 29, 16, p. 3092-3100 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Lasofoxifene versus fulvestrant for ER+/HER2− metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trial
Goetz, M. P., Bagegni, N. A., Batist, G., Brufsky, A., Cristofanilli, M. A., Damodaran, S., Daniel, B. R., Fleming, G. F., Gradishar, W. J., Graff, S. L., Grosse Perdekamp, M. T., Hamilton, E., Lavasani, S., Moreno-Aspitia, A., O'Connor, T., Pluard, T. J., Rugo, H. S., Sammons, S. L., Schwartzberg, L. S. & Stover, D. G. & 7 others, , Dec 2023, In: Annals of Oncology. 34, 12, p. 1141-1151 11 p.Research output: Contribution to journal › Article › peer-review
Open Access10 Scopus citations -
Use of Circulating Tumor DNA (ctDNA) for Early Molecular Detection of Breast Cancer Relapse in Patients with Triple-Negative Breast Cancer (TNBC)
Bagegni, N. A. & Ademuyiwa, F. O., Dec 2023, In: Current Breast Cancer Reports. 15, 4, p. 356-363 8 p.Research output: Contribution to journal › Review article › peer-review
-
Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer
Davis, A. A., Gerratana, L., Clifton, K., Medford, A. J., Velimirovic, M., Hensing, W. L., Bucheit, L., Shah, A. N., D'Amico, P., Reduzzi, C., Zhang, Q., Dai, C. S., Denault, E. N., Bagegni, N. A., Opyrchal, M., Ademuyiwa, F. O., Bose, R., Gradishar, W. J., Behdad, A. & Ma, C. X. & 2 others, , Dec 2022, In: EBioMedicine. 86, 104316.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations